ICD-O: Difference between revisions
Feedback

From WikiLectures

mNo edit summary
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
The International Classification of Diseases for Oncology (ICD-O) is derived from the [ICD-O] for oncological diagnoses. The third revision of the ICD-O is currently in use. Tumors are coded in the following axes:
__NOTOC__
 
'''The International Classification of Diseases for Oncology''' (ICD-O) is derived from the [[International classification of diseases|International Classification of Diseases]] for oncological diagnoses. The third revision of the ICD-O is currently in use. Tumors are coded in the following axes:
*topography
*topography
*morphology
*morphology
*biological behavior
*biological behaviour
*differentiation
*differentiation
'' 'The classification is expressed by a combination of a three- to four-digit alphanumeric topography code' '' (eg C01.1) '' 'b' ''  a five-digit code  'XXXX / Y' , where the first four digits indicate the morphological type of the tumor and the number after the slash biological behavior. The next (optional) digit (sometimes listed second after the slash in the data collection) indicates the degree of tumor differentiation. Morphological codes ('' XXXX '') are always four-digit numbers between 8000 and 9989. '' '''


'' 'The biological behavior code (' 'Y' ') can take the following values:' ''
'''The classification is expressed by a combination of a three- to four-digit alphanumeric code of topography''' (e.g. C01.1) '''b a five-digit code''' ''XXXX/Y''''', where the first four digits indicate the morphological type of the tumor and the digit after the slash biological behavior. The next (optional) number (sometimes listed second after the slash in data collections) indicates the degree of differentiation of the tumor. Morphological codes ( ''XXXX'' ) are always four-digit numbers from the interval 8000 to 9989.'''
*'''''0''''' - benign tumor
 
*'''''1'''''  - uncertain behavior, it is not certain whether it is a benign or malignant tumor
'''The biological behavior code ( ''Y'' ) can take on the following values:'''
*'''''2''''' - tumor in situ, non-invasive
*'''''0''''' benign tumor
*'''''3''''' - malignant tumor, primary
*'''''1''''' uncertain behavior, it is not certain whether it is a benign or malignant tumor
*'''''6''''' - malignant tumor, metastatic (not used in oncology registries)
*'''''2''''' tumor in situ, non-invasive
*'''''9''''' - malignant tumor, origin cannot be determined (not used in oncology registries)
*'''''3''''' malignant tumor, primary
'' 'The differentiation code has the meaning of histological grading and differentiation:' ''
*'''''6''''' malignant tumor, metastatic (not used in oncology registries)
*'''''1''''' - well differentiated
*'''''9''''' malignant tumor, origin cannot be determined (not used in oncology registries)
*'''''2''''' - moderately well differentiated
 
*'''''3''''' - poorly differentiated
'''The differentiation code has the meaning of histological grading and differentiation:'''
*'''''4''''' - undifferentiated, anaplastic
*'''''1''''' well differentiated
*'''''9''''' - differentiation not specified, not specified or not applicable
*'''''2''''' moderately well differentiated
'' 'In the case of [[Lymphoma | lymphomas]] and [[Leukemia | leukemias]], the gross immunophenotype is given instead of the differentiation code in the National Cancer Registry:' ''
*'''''3''''' poorly differentiated
*'''''5''''' - immunoprofile corresponds to [[T-lymphocytes | T-lymphocytes]]
*'''''4''''' undifferentiated, anaplastic
*'''''6''''' - immunoprofile corresponds to [[B-lymphocytes | B-lymphocytes]]
*'''''9''''' differentiation not determined, not stated or cannot be used
*'''''7''''' - immunoprofile of null cells (non-B non-T cells)
 
*'''''8''''' - immunoprofile corresponds to [[NK cells | NK cells]]
'''In the case of [[Malignant lymphoma|lymphomas]] and [[Leukemia|leukemias]], instead of the differentiation code, the gross immunophenotype is given in the National Cancer Registry:'''
*'''''9''''' - cell type not specified, not specified or not applicable
 
The classification is derived from the ICD-10 classification. Thus, the topography / localization coding for malignant neoplasms usually corresponds to the ICD-10 code. An exception is, for example, codes that already take into account the morphological type of neoplasm in ICD-10. For example, code C43.5 Malignant melanoma is code C44.3 (Torso skin) 8720/3 (Malignant melanoma NS) in ICD-O.
*'''''5''''' immunoprofile corresponds to [[T lymphocytes]]
*'''''6''''' immunoprofile corresponds to [[B lymphocytes]]
*'''''7''''' immunoprofile of null cells (non-B non-T cells)
*'''''8''''' immunoprofile corresponds to [[NK cells]]
*'''''9''''' cell type unspecified, not specified or unusable
 
 
The classification is derived from the ICD-10 classification. Therefore, the coding of topography/localization for malignant neoplasms usually corresponds to the ICD-10 code. An exception is, for example, codes that already take into account the morphological type of neoplasm in ICD-10. For example, the code C43.5 Malignant melanoma of trunk is coded in ICD-O as C44.3 (Skin of trunk) 8720/3 (Malignant melanoma NS).
 
'''Example of interpretation of coding C24.1 M-8160/32:'''
*'''C24''' – (malignant) neoplasm of other and unspecified parts of the biliary tract
*'''C24.1''' – Vater papilla tumor
*'''C24.1 8160''' – cholangiocarcinoma of Vater's papilla
*'''C24.1 8160/3''' – (malignant) cholangiocarcinoma of Vater's papilla
*'''C24.1 8160/32''' – moderately well-differentiated cholangiocarcinoma of Vater's papilla


'' 'Example of C24.1 encoding interpretation M-8160/32:' ''
*'''C24''' - (malignant) neoplasm of other and unspecified parts of bile ducts
*'''C24.1''' - Vater papilla tumor
*'''C24.1 8160''' - cholangiocarcinoma Vater papilla
*'''C24.1 8160/3''' - (malignant) cholangiocarcinoma Vater papilla
*'''C24.1 8160/32''' - moderately well differentiated cholangiocarcinoma Vater papilla
==Links==
==Links==
==Source==
*[[ws:MKN-O]]
===Related Articles===
===Related Articles===
* [[International Classification of Diseases]]
 
* [[Classification systems in psychiatry]]
*[[International classification of diseases]]
*[[Classification systems in psychiatry]]
 
===Literature===
===Literature===
*{{Quote
 
* {{Cite
   | type = book
   | type = book
   | corporation = WHO
   | corporation = WHO
   | title = International Classification of Diseases for Oncology
   | title = International Classification of Diseases for Oncology
   | issue = 3
   | edition = 3
   | year = 2004
   | year = 2004
   | publisher = ÚZIS
   | publisher = ÚZIS
Line 51: Line 62:
}}
}}


=== External links===
===External links===
 
*[https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3)]
*[https://www.who.int/standards/classifications/other-classifications/international-classification-of-diseases-for-oncology International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3)]
*[http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577 ICD-O on the International Association of Cancer Registries website]
*[http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577 ICD-O na webu International Association of Cancer Registries]
*[https://www.uzis.cz/mkn-o Czech translation of ICD-O on the IHIS CR website]
*[https://www.uzis.cz/mkn-o český překlad ICD-O na webu ÚZIS ČR]
 
[[Category:Oncology]]
[[Category:Pathology]]
[[Category:Health statistics]]

Latest revision as of 11:12, 1 May 2023


The International Classification of Diseases for Oncology (ICD-O) is derived from the International Classification of Diseases for oncological diagnoses. The third revision of the ICD-O is currently in use. Tumors are coded in the following axes:

  • topography
  • morphology
  • biological behaviour
  • differentiation

The classification is expressed by a combination of a three- to four-digit alphanumeric code of topography (e.g. C01.1) b a five-digit code XXXX/Y, where the first four digits indicate the morphological type of the tumor and the digit after the slash biological behavior. The next (optional) number (sometimes listed second after the slash in data collections) indicates the degree of differentiation of the tumor. Morphological codes ( XXXX ) are always four-digit numbers from the interval 8000 to 9989.

The biological behavior code ( Y ) can take on the following values:

  • 0 – benign tumor
  • 1 – uncertain behavior, it is not certain whether it is a benign or malignant tumor
  • 2 – tumor in situ, non-invasive
  • 3 – malignant tumor, primary
  • 6 – malignant tumor, metastatic (not used in oncology registries)
  • 9 – malignant tumor, origin cannot be determined (not used in oncology registries)

The differentiation code has the meaning of histological grading and differentiation:

  • 1 – well differentiated
  • 2 – moderately well differentiated
  • 3 – poorly differentiated
  • 4 – undifferentiated, anaplastic
  • 9 – differentiation not determined, not stated or cannot be used

In the case of lymphomas and leukemias, instead of the differentiation code, the gross immunophenotype is given in the National Cancer Registry:

  • 5 – immunoprofile corresponds to T lymphocytes
  • 6 – immunoprofile corresponds to B lymphocytes
  • 7 – immunoprofile of null cells (non-B non-T cells)
  • 8 – immunoprofile corresponds to NK cells
  • 9 – cell type unspecified, not specified or unusable


The classification is derived from the ICD-10 classification. Therefore, the coding of topography/localization for malignant neoplasms usually corresponds to the ICD-10 code. An exception is, for example, codes that already take into account the morphological type of neoplasm in ICD-10. For example, the code C43.5 Malignant melanoma of trunk is coded in ICD-O as C44.3 (Skin of trunk) 8720/3 (Malignant melanoma NS).

Example of interpretation of coding C24.1 M-8160/32:

  • C24 – (malignant) neoplasm of other and unspecified parts of the biliary tract
  • C24.1 – Vater papilla tumor
  • C24.1 8160 – cholangiocarcinoma of Vater's papilla
  • C24.1 8160/3 – (malignant) cholangiocarcinoma of Vater's papilla
  • C24.1 8160/32 – moderately well-differentiated cholangiocarcinoma of Vater's papilla

Links[edit | edit source]

Related Articles[edit | edit source]

Literature[edit | edit source]

  • WHO. . International Classification of Diseases for Oncology. 3. edition. ÚZIS, 2004. translation of the 3rd edition of the International Classification of Diseases for Oncology from 2000, translated by V. Mandys. ISBN 80-7280-373-5.


External links[edit | edit source]